Inj glucagon hcl, fresenius
Products billed under this code include Glucagen, Glucagon, Glucagon Emergency.
Payment limit per 1 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Glucagen, Glucagon, Glucagon Emergency.
Payment limit per 1 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Glucagen | FreseniUS Kabi USA, LLC | 63323-0594-03 | 1 | $134.892 |
| Glucagon | FreseniUS Kabi USA, LLC | 63323-0593-03 | 1 | $134.892 |
| Glucagon | FreseniUS Kabi USA, LLC | 63323-0596-13 | 10 | $1,348.92 |
| Glucagon | FreseniUS Kabi USA, LLC | 63323-0596-16 | 10 | $1,348.92 |
| Glucagon Emergency | FreseniUS Kabi USA, LLC | 63323-0582-82 | 1 | $134.892 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $134.892 | +$5.611 | 1 MG | Inj glucagon hcl, fresenius | v1, posted September 17, 2026 |
| 3Q26 | $129.281 | −$5.719 | 1 MG | Inj glucagon hcl, fresenius | v1, posted September 15, 2026 |
| 2Q26 | $135.00 | −$8.254 | 1 MG | Inj glucagon hcl, fresenius | v1, posted September 15, 2026 |
| 1Q26 | $143.254 | −$5.735 | 1 MG | Inj glucagon hcl, fresenius | v1, posted September 15, 2026 |
| 4Q25 | $148.989 | +$4.107 | 1 MG | Inj glucagon hcl, fresenius | v1, posted September 8, 2026 |
| 3Q25 | $144.882 | −$5.555 | 1 MG | Inj glucagon hcl, fresenius | v1, posted March 10, 2026 |
| 2Q25 | $150.437 | +$38.529 | 1 MG | Inj glucagon hcl, fresenius | v1, posted March 10, 2026 |
| 1Q25 | $111.908 | +$2.983 | 1 MG | Inj glucagon hcl, fresenius | v1, posted December 19, 2025 |
| 4Q24 | $108.925 | −$20.74 | 1 MG | Inj glucagon hcl, fresenius | v1, posted June 11, 2025 |
| 3Q24 | $129.665 | +$0.781 | 1 MG | Inj glucagon hcl, fresenius | v1, posted June 11, 2025 |
| 2Q24 | $128.884 | +$5.054 | 1 MG | Inj glucagon hcl, fresenius | v1, posted March 11, 2025 |
| 1Q24 | $123.83 | +$13.068 | 1 MG | Inj glucagon hcl, fresenius | v1, posted December 19, 2024 |
| 4Q23 | $110.762 | +$9.35 | 1 MG | Inj glucagon hcl, fresenius | v1, posted October 10, 2024 |
| 3Q23 | $101.412 | −$47.629 | 1 MG | Inj glucagon hcl, fresenius | v1, posted June 5, 2024 |
| 2Q23 | $149.041 | −$12.971 | 1 MG | Inj glucagon hcl, fresenius | v1, posted February 23, 2024 |
| 1Q23 | $162.012 | – | 1 MG | Inj glucagon hcl, fresenius | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.